None listed
Conditions
Brief summary
The SupportME is a pragmatic, multicentre, single-blinded, parallel-group, randomised controlled trial to determine the effect of mobile phone text messaging intervention on blood pressure for patients with diabetes and cardiovascular diseases. This study was funded by NSW Translational Research Grant. It aims to recruit 1000 patients with coronary heart diseases and/or type 2 diabetes. Patients will be randomised to text messaging intervention or standard-of-care. The primary outcome is the difference between groups in systolic blood pressure at 6 months.
Interventions
The SupportMe intervention is a simple patient-centered text messaging intervention designed to provide semi-personalized support in clinical and behavioral management and link patients with providers and health services (hospital, community and GP). Messages will provide advice, motivation, information and support on their disease condition and tips to engage in healthy behaviours. The intervention will be individualised based on baseline information and clinical context, for example, non-smoke
The SupportMe intervention is a simple patient-centered text messaging intervention designed to provide semi-personalized support in clinical and behavioral management and link patients with providers and health services (hospital, community and GP). Messages will provide advice, motivation, information and support on their disease condition and tips to engage in healthy behaviours. The intervention will be individualised based on baseline information and clinical context, for example, non-smokers will not receive text messages on smoking. The 6 months intervention with 4 text messages per week will be sent to participant’s mobile phone. The message delivery software will monitor delivery of message i.e whether messages are delivered to participants. This will be followed by a 6 months maintenance phase where participants will receive 3-4 text messages per month.
Sponsors
Western Sydney Local Health District
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients will be 18 years or older, provide informed consent, be referred by a clinician in the WSLHD and meet all of the following: a) At least one of the following clinical criteria: 1. Coronary heart disease (CHD) defined as documented prior myocardial infarction, coronary artery bypass graft surgery, percutaneous coronary intervention, or 50% or greater stenosis in at least 1 major epicardial vessel on coronary angiography. 2. Type 2 Diabetes as diagnosed by a physician with an HbA1C greater than 7.o% and less than or equal to 11.0% b) Own a mobile phone c) Read text messages in English or one of the limited number of languages that we will provide in the program
Exclusion criteria
a. Unable to complete the study procedures and/or follow-up b. Any condition that in the opinion of the responsible physician or investigator that renders the patient unsuitable for the study (e.g. severe disability or significant memory or behavioural disorder)
Outcome results
None listed